Homocysteine, hydrogen sulfide (H2S) and NMDA-receptor in heart failure

Indian Journal of Biochemistry and Biophysics

Volumn 46, Issue 6, 2009, Pages 441-446

  Tyagi, Neetu ^a   Mishra, Paras K ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Calcium transient; Cystathionine synthase cystathionine lyase; Homocysteine; Hydrogen sulfide; Hyperhomocysteinemia; Mitochondrial matrix metalloproteinase; Mitochondrial permeability; Myocyte mechanics; NMDA r1

Indexed keywords

HOMOCYSTEINE; HYDROGEN SULFIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL; GENE DELETION; GENETICS; HEART CONTRACTION; HEART FAILURE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; GENE DELETION; HEART FAILURE; HOMOCYSTEINE; HUMANS; HYDROGEN SULFIDE; MYOCARDIAL CONTRACTION; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84924270332     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. 2S) - the third gas of interest for pharmacologists. Pharmacol Rep 59, 4-24
2. Szabo C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6, 917-935
3. Zhang Z, Huang H, Liu P, Tang C & Wang J (2007) Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening K ATP channels. Can J Physiol Pharmacol 85, 1248-1253
4. Chang L, Geng B, Yu F, Zhao J, Jiang H, Du J & Tang C (2008) Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids 34, 573-585
5. Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R & Thiemermann C (2009) Anti apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock 31, 267-274
6. Bhatia M (2005) Hydrogen sulfide as a vasodilator. IUBMB Life 57, 603-606
7. Chen C Q, Xin H & Zhu Y Z (2007) Hydrogen sulfide, third gaseous transmitter, but with great pharmacological potential. Acta Pharmacol Sin 28, 1709-1716
8. Kimura Y, Dargusch R, Schubert D & Kimura H (2006) Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid Redox Signal 8, 661-670
9. Kimura Y & Kimura H (2004) Hydrogen sulfide protects neurons from oxidative stress. FASEB J 18, 1165-1167
10. Teng X, Isbell T S, Crawford J H, Bosworth C A, Giles G I, Koenitzer J R, Lancaster J R, Doeller J E, Kraus D W & Patel R P (2008) Novel method for measuring S-nitrosothiols using hydrogen sulfide. Meth Enzymol 441, 161-172
11. Raffetto J D & Khalil R A (2008) Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 75, 346-359
12. Moshal K S, Tyagi N, Moss V, Henderson B, Steed M, Ovechkin A, Aru G M & Tyagi S C (2005) Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure. J Cell Mol Med 9, 704-713
13. Mujumdar V S, Smiley L M & Tyagi S C (2001) Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. Int J Cardiol 79, 277-286
14. Mujumdar V S & Tyagi S C (1999) Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure. J Hypertens 17, 261-270
15. Stetler-Stevenson W G (2008) Tissue inhibitors of metalloproteinases in cell-signaling, Metalloproteinaseindependent biological activity. Sci. Signal 1, re6
16. Lindsay M M, Maxwell P & Dunn F G (2002) TIMP-1, a marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 40, 136-141
17. Baker A H, Zaltsman A B, George S J & Newby A C (1998) Divergent effects of tissue inhibitor of metalloproteinase-1,-2, or-3 over expression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 101, 1478-1487
18. Moshal K S, Kumar M, Tyagi N, Mishra P K, Metreveli N, Rodriguez W E & Tyagi S C (2009) Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1. Am J Physiol Heart Circ Physiol 296, H887-892
19. Singh K, Communal C, Sawyer D B & Colucci W S (2000) Adrenergic regulation of myocardial apoptosis. Cardiovasc Res 45, 713-719
20. Li Y F, Cornish K G & Patel K P (2003) Alteration of NMDA NR[1] receptors within the paraventricular nucleus of hypothalamus in rats with heart failure. Circ Res 93, 990-997
21. D'Amico M, Filippo C & Di Rossi F (1999) Arrhythmias induced by myocardial ischemia-reperfusion are sensitive to ionotrophic excitatory amino acid receptor antagonists. Eur J Pharmacol 366, 167-174
22. Herrmann M, Kindermann I, Müller S, Georg T, Kindermann M, Böhm M & Herrmann W (2005) Relationship of plasma homocysteine with the severity of chronic heart failure. Clin Chem 51, 1512-1515
23. James T N, Carson N A J & Froggatt P (1974) Coronary vessels and conduction system in homocystinuria. Circulation XLIX, 367-374
24. Bollani G, Ferrari R, Bersatti F, Ferrari M, Cattaneo M, Zighetti M I, Visioli O & Sanelli D (1999) A hyperhomocysteinemia study in a population with a familial factor for acute MI and SCD at a young age. Cardiologia 44, 75-81
25. Burke A P, Fonseca V, Kolodgie F, Zieske A, Fink L & Virmani R (2002) Increased serum Hcy and SCD resulting from coronary atherosclerosis with fibrous plaques. Arterioscler Thromb Vasc Biol 22, 1936-1941
26. Albert C M, Rifai N, Stampfer M J & Ridker P M (2002) Prospective study of C-reactive protein, Hcy and plasma lipid levels as predictors of SCD. Circulation 105, 2595-2599
27. Herrmann W, Herrmann M, Joseph J & Tyagi S C (2007) Homocysteine, brain natriuretic peptide and chronic heart failure, a critical review. Clin Chem Lab Med 45, 1633-1644
28. Folbergrova J (1994) NMDA and not non-NMDA receptor antagonists are protective against seizures induced by homocysteine in neonatal rats. Exp Neurol 130, 344-350
29. Moshal K S, Tipparaju S M, Vacek T P, Kumar M, Singh M, Frank I E, Patibandala P K, Tyagi N, Rai J, Metreveli N, Rodriguez W E, Tseng M T & Tyagi S C (2008) Mitochondrial Matrix Metalloproteinase Activation Decreases Myocyte Contractility in Hyperhomocysteinemia. Am J Physiol Heart Circ Physiol 295, H890-897
30. Schulz R (2007) Intracellular targets of matrix metalloproteinase-2 in cardiac disease, rationale and therapeutic approaches. Annu Rev Pharmacol Toxicol 47, 211-242
31. Gao X, Xu X B, Pang J, Zhang C, Ding J M, Peng X, Liu Y & Cao J M (2007) NMDA receptor activation induces mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardio. Physiol Res 56, 559-569